A narrative review on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis versus hepatocellular carcinoma: do you mind?

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00843989%3A_____%2F22%3AE0109670" target="_blank" >RIV/00843989:_____/22:E0109670 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/70883521:28150/22:63553638

Výsledek na webu

<a href="https://www.scielo.br/j/ramb/a/LDGxFVDXtkQRBNCNTRyXxtq/?lang=en" target="_blank" >https://www.scielo.br/j/ramb/a/LDGxFVDXtkQRBNCNTRyXxtq/?lang=en</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1590/1806-9282.20220268" target="_blank" >10.1590/1806-9282.20220268</a>

Jazyk výsledku

angličtina

Název v původním jazyce

A narrative review on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis versus hepatocellular carcinoma: do you mind?

Popis výsledku v původním jazyce

Nonalcoholic fatty liver disease (NAFLD) is a predominant etiologic factor for liver disease. The risk of the development of hepatocellular carcinoma (HCC) in cases suffering from NAFLD has been stated1. Nonalcoholic steatohepatitis (NASH), a subtype of NAFLD, is a well-known etiologic factor for cirrhosis and it is one of the risk factors for the development of HCC2. In addition, the association of obesity with NAFLD is well established and augmentation in obesity has been associated with an increase in the incidence of HCC1,3. In the present review, the interrelation of NAFLD and HCC, obesity and NAFLD, and obesity and HCC has been purposed to be discussed by taking into consideration the relevant prevalence, clinical evidence, pathogenic mechanisms, and diagnostic parameters.

Název v anglickém jazyce

A narrative review on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis versus hepatocellular carcinoma: do you mind?

Popis výsledku anglicky

Nonalcoholic fatty liver disease (NAFLD) is a predominant etiologic factor for liver disease. The risk of the development of hepatocellular carcinoma (HCC) in cases suffering from NAFLD has been stated1. Nonalcoholic steatohepatitis (NASH), a subtype of NAFLD, is a well-known etiologic factor for cirrhosis and it is one of the risk factors for the development of HCC2. In addition, the association of obesity with NAFLD is well established and augmentation in obesity has been associated with an increase in the incidence of HCC1,3. In the present review, the interrelation of NAFLD and HCC, obesity and NAFLD, and obesity and HCC has been purposed to be discussed by taking into consideration the relevant prevalence, clinical evidence, pathogenic mechanisms, and diagnostic parameters.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30212 - Surgery

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2022

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Revista da Associaçao Médica Brasileira

ISSN

0104-4230

e-ISSN

1806-9282

Svazek periodika

68

Číslo periodika v rámci svazku

6

Stát vydavatele periodika

BR - Brazilská federativní republika

Počet stran výsledku

4

Strana od-do

871-874

Kód UT WoS článku

000823735900031

EID výsledku v databázi Scopus

2-s2.0-85133214185